In Enzo Biochem, Inc. v. Applera Corp. , No. 09-1281 (Fed. Cir. Mar. 26, 2010), the Federal Circuit reversed the district court’s ruling that the claims of U.S. Patent Nos. 5,328,824 (“the ‘824 patent”), 5,449,767 (“the ‘767 patent”), and 5,476,928 (“the ‘928 patent”) were indefinite.